1351410-69-9

Basic information

• Product Name: N-(3-(4-(6-fluoropyridin-2-yl)piperazin-1-yl)propyl)cyclohexanecarboxamide
• Synonyms: N-(3-(4-(6-fluoropyridin-2-yl)piperazin-1-yl)propyl)cyclohexanecarboxamide
• CAS NO: 1351410-69-9
• Molecular Weight: 348.464
• Mol File: 1351410-69-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(3-(4-(6-fluoropyridin-2-yl)piperazin-1-yl)propyl)cyclohexanecarboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(3-(4-(6-fluoropyridin-2-yl)piperazin-1-yl)propyl)cyclohexanecarboxamide(1351410-69-9)
• EPA Substance Registry System: N-(3-(4-(6-fluoropyridin-2-yl)piperazin-1-yl)propyl)cyclohexanecarboxamide(1351410-69-9)

Safety Data

• Hazardous Substances Data: 1351410-69-9(Hazardous Substances Data)

Upstream product

• 1351411-88-5 2-(3-(4-(6-fluoropyridin-2-yl)piperazin-1-yl)propyl)isoindoline-1,3-dione 
• 223514-16-7 1-(6-fluoropyridin-2-yl)piperazine 
• 1351411-89-6 3-(4-(6-fluoropyridin-2-yl)piperazin-1-yl)propan-1-amine 
• 2719-27-9 cyclohexanylcarbonyl chloride 

Relevant articles and documents

RADIOLABELED COMPOUNDS AND METHODS THEREOF

The present invention relates to radiodiagnostic compounds, methods of making those compounds, and methods of use thereof as imaging agents for preferably a HA serotonin 5-HT1A receptor for use in PET or SPECT, preferably PET. Compositions comprising an imaging-effective amount of radiolabeled compounds are also disclosed. The present invention also relates to non-radiolabeled compounds, methods of making those compounds, and methods of use thereof to treat various neurological and/or psychiatric disorders.